Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$9.15 /

-0.09 (-0.97%)

07:07
01/22/21
01/22
07:07
01/22/21
07:07

BioCryst announces approval of ORLADEYO in Japan

BioCryst Pharmaceuticals announced that the Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing approval for oral, once-daily ORLADEYO 150 mg for prophylactic treatment of hereditary angioedema in adults and pediatric patients 12 years and older. ORLADEYO is the first and only prophylactic HAE medication approved in Japan. One capsule of ORLADEYO per day works to prevent HAE attacks by decreasing the activity of plasma kallikrein. ORLADEYO will be commercialized in Japan by BioCryst's partner, Torii Pharmaceutical Co., Ltd. OrphanPacific, Inc. is BioCryst's representative partner in Japan and holds the marketing authorization. Torii will launch ORLADEYO in Japan following the successful completion of BioCryst's pricing negotiations with the Japanese National Health Insurance System. In December 2020, the U.S. Food & Drug Administration approved ORLADEYO in the U.S. In Europe, the European Medicines Agency validated its marketing authorization application submission for ORLADEYO and formal review of the MAA under the centralized procedure is underway. The company expects an approval decision in Europe in the second quarter of 2021. With the approval in Japan, BioCryst is eligible to receive an additional milestone payment of $15M from Torii upon receipt of a reimbursement price approval from Japan's National Health Insurance system in excess of the threshold specified in the agreement with Torii. In addition, BioCryst will receive tiered royalties ranging from 20 percent to potentially 40 percent of Japanese net sales.

  • 28

    May

BCRX BioCryst
$9.15 /

-0.09 (-0.97%)

12/22/20 JMP Securities
BioCryst selloff today a buying opportunity, says JMP Securities
12/07/20 H.C. Wainwright
BioCryst price target raised to $14 from $13 at H.C. Wainwright
12/04/20 Piper Sandler
BioCryst receives on-time approval with 'clean' label, says Piper Sandler
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI

TODAY'S FREE FLY STORIES

Initiation
Neximmune initiated with an Overweight at Cantor Fitzgerald » 07:06
03/09/21
03/09
07:06
03/09/21
07:06
NEXI

Neximmune

$20.25 /

+1.24 (+6.52%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEXI Neximmune
$20.25 /

+1.24 (+6.52%)

  • 12
    Feb
NEXI Neximmune
$20.25 /

+1.24 (+6.52%)

Hot Stocks
Soligenix receives preliminary approval for tax credit from NJEDA » 07:06
03/09/21
03/09
07:06
03/09/21
07:06
SNGX

Soligenix

$1.56 /

+0.03 (+1.97%)

Soligenix announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNGX Soligenix
$1.56 /

+0.03 (+1.97%)

SNGX Soligenix
$1.56 /

+0.03 (+1.97%)

12/23/20 Alliance Global Partners
Soligenix price target lowered to $5.75 from $7.25 at Alliance Global Partners
12/04/20 B. Riley Securities
B. Riley sees 100% upside in Soligenix, starts with Buy rating
12/04/20 B. Riley Securities
Soligenix initiated with a Buy at B. Riley Securities
07/28/20 Dawson James
Soligenix downgraded to Neutral from Buy at Dawson James
SNGX Soligenix
$1.56 /

+0.03 (+1.97%)

Hot Stocks
Penske Automotive rebrands U.S.-based used vehicle SuperCenters » 07:06
03/09/21
03/09
07:06
03/09/21
07:06
PAG

Penske Automotive

$80.01 /

+2.13 (+2.73%)

Penske Automotive Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAG Penske Automotive
$80.01 /

+2.13 (+2.73%)

PAG Penske Automotive
$80.01 /

+2.13 (+2.73%)

02/11/21 Stephens
Penske Automotive price target raised to $78 from $70 at Stephens
02/10/21 Morgan Stanley
Morgan Stanley cuts Lithia Motors to sell with shares near bull case
01/15/21 Truist
Penske Automotive price target raised to $75 from $65 at Truist
12/07/20 Morgan Stanley
Morgan Stanley upgrades Asbury, downgrades Lithia in auto dealer rating shake-up
PAG Penske Automotive
$80.01 /

+2.13 (+2.73%)

PAG Penske Automotive
$80.01 /

+2.13 (+2.73%)

Downgrade
Acadia downgraded to Hold from Buy at Stifel » 07:06
03/09/21
03/09
07:06
03/09/21
07:06
ACAD

Acadia

$45.83 /

-3.22 (-6.56%)

Stifel analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia
$45.83 /

-3.22 (-6.56%)

ACAD Acadia
$45.83 /

-3.22 (-6.56%)

06:52 Today Mizuho
Acadia price target lowered to $55 from $70 at Mizuho
06:34 Today Citi
Acadia downgraded to Neutral from Buy at Citi
06:12 Today H.C. Wainwright
Acadia price target lowered to $43 from $60 at H.C. Wainwright
06:10 Today RBC Capital
Acadia price target lowered to $36 from $60 at RBC Capital
ACAD Acadia
$45.83 /

-3.22 (-6.56%)

ACAD Acadia
$45.83 /

-3.22 (-6.56%)

Earnings
Xeris Pharmaceuticals reports Q4 EPS (41c), consensus (38c) » 07:05
03/09/21
03/09
07:05
03/09/21
07:05
XERS

Xeris Pharmaceuticals

$4.71 /

-0.12 (-2.48%)

Reports Q4 revenue $7.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$4.71 /

-0.12 (-2.48%)

XERS Xeris Pharmaceuticals
$4.71 /

-0.12 (-2.48%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
XERS Xeris Pharmaceuticals
$4.71 /

-0.12 (-2.48%)

  • 26
    Jun
XERS Xeris Pharmaceuticals
$4.71 /

-0.12 (-2.48%)

XERS Xeris Pharmaceuticals
$4.71 /

-0.12 (-2.48%)

Earnings
Allena Pharmaceuticals reports Q4 EPS (24c), consensus (19c) » 07:05
03/09/21
03/09
07:05
03/09/21
07:05
ALNA

Allena Pharmaceuticals

$1.51 /

+0.045 (+3.07%)

"Building on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
$1.51 /

+0.045 (+3.07%)

ALNA Allena Pharmaceuticals
$1.51 /

+0.045 (+3.07%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
ALNA Allena Pharmaceuticals
$1.51 /

+0.045 (+3.07%)

  • 02
    Dec
Recommendations
Stitch Fix price target raised to $40 from $35 at BMO Capital » 07:05
03/09/21
03/09
07:05
03/09/21
07:05
SFIX

Stitch Fix

$68.05 /

-4.94 (-6.77%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$68.05 /

-4.94 (-6.77%)

SFIX Stitch Fix
$68.05 /

-4.94 (-6.77%)

06:36 Today Piper Sandler
Stitch Fix price target raised to $47 from $38 at Piper Sandler
05:25 Today Deutsche Bank
Stitch Fix downgraded to Hold from Buy at Deutsche Bank
02/01/21 Stifel
Stitch Fix downgraded to Hold from Buy at Stifel
01/29/21 Baird
Stitch Fix downgraded on valuation after 'short squeze' at Baird
SFIX Stitch Fix
$68.05 /

-4.94 (-6.77%)

SFIX Stitch Fix
$68.05 /

-4.94 (-6.77%)

SFIX Stitch Fix
$68.05 /

-4.94 (-6.77%)

Hot Stocks
Lindblad Expeditions acquires stakes in DuVine Cycling, Off the Beaten Path » 07:04
03/09/21
03/09
07:04
03/09/21
07:04
LIND

Lindblad Expeditions

$19.50 /

+0.17 (+0.88%)

Lindblad Expeditions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIND Lindblad Expeditions
$19.50 /

+0.17 (+0.88%)

LIND Lindblad Expeditions
$19.50 /

+0.17 (+0.88%)

10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
04/28/20 Stifel
Lindblad demand should return faster than 'normal' cruises, says Stifel
04/22/20 Deutsche Bank
Lindblad Expeditions price target lowered to $7 from $16 at Deutsche Bank
04/13/20 Sidoti
Lindblad Expeditions downgraded to Neutral from Buy at Sidoti
LIND Lindblad Expeditions
$19.50 /

+0.17 (+0.88%)

Hot Stocks
Glazer Capital urges QEP investors to vote against acquisition by Diamondback » 07:04
03/09/21
03/09
07:04
03/09/21
07:04
QEP

QEP Resources

$4.33 /

+0.055 (+1.29%)

, FANG

Diamondback Energy

$84.16 /

-1.04 (-1.22%)

Glazer Capital, LLC, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QEP QEP Resources
$4.33 /

+0.055 (+1.29%)

FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

QEP QEP Resources
$4.33 /

+0.055 (+1.29%)

01/25/21 Stifel
QEP Resources downgraded to Hold from Buy at Stifel
12/28/20 Northland
Diamondback Energy price target raised to $60 from $50 at Northland
12/22/20 Stephens
Diamondback Energy price target raised to $67 from $56 at Stephens
12/22/20 Susquehanna
Diamondback Energy deal strengthens free cash flow, says Susquehanna
FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

03/08/21 Truist
Diamondback Energy price target raised to $105 from $80 at Truist
02/24/21 Susquehanna
Diamondback Energy price target raised to $83 from $79 at Susquehanna
02/24/21 Truist
Diamondback Energy price target raised to $80 from $65 at Truist
02/22/21 Roth Capital
Diamondback Energy price target raised to $84 from $49 at Roth Capital
QEP QEP Resources
$4.33 /

+0.055 (+1.29%)

FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

QEP QEP Resources
$4.33 /

+0.055 (+1.29%)

FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

FANG Diamondback Energy
$84.16 /

-1.04 (-1.22%)

Hot Stocks
DocGo to become public through Motion Acquisition business combination » 07:04
03/09/21
03/09
07:04
03/09/21
07:04
MOTN

Motion Acquisition

$9.81 /

+ (+0.00%)

, DCGO

DocGo

$0.00 /

+ (+0.00%)

Ambulnz, to be renamed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Children's Place not providing EPS guidance » 07:03
03/09/21
03/09
07:03
03/09/21
07:03
PLCE

Children's Place

$79.99 /

+4.6 (+6.10%)

As a result of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Monness Crespi
Monness Crespi downgrades Children's Place to Neutral, sees recovery priced in
02/16/21 Monness Crespi
Children's Place downgraded to Neutral from Buy at Monness Crespi
02/12/21 Citi
Children's Place downgraded to Sell from Neutral at Citi
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

Hot Stocks
Children's Place plans to close 122 stores in 2021 » 07:03
03/09/21
03/09
07:03
03/09/21
07:03
PLCE

Children's Place

$79.99 /

+4.6 (+6.10%)

As of January 30, 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Monness Crespi
Monness Crespi downgrades Children's Place to Neutral, sees recovery priced in
02/16/21 Monness Crespi
Children's Place downgraded to Neutral from Buy at Monness Crespi
02/12/21 Citi
Children's Place downgraded to Sell from Neutral at Citi
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

Recommendations
Mohawk Group price target raised to $48 from $34 at Alliance Global Partners » 07:02
03/09/21
03/09
07:02
03/09/21
07:02
MWK

Mohawk Group

$36.19 /

+2.28 (+6.72%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MWK Mohawk Group
$36.19 /

+2.28 (+6.72%)

MWK Mohawk Group
$36.19 /

+2.28 (+6.72%)

03/05/21 Sidoti
Mohawk Group upgraded to Buy from Neutral at Sidoti
02/18/21 Sidoti
Mohawk Group downgraded to Neutral from Buy at Sidoti
02/09/21 Oppenheimer
Mohawk Group price target raised to $50 from $30 at Oppenheimer
02/03/21 Roth Capital
Mohawk Group price target raised to $37 from $16 at Roth Capital
MWK Mohawk Group
$36.19 /

+2.28 (+6.72%)

MWK Mohawk Group
$36.19 /

+2.28 (+6.72%)

MWK Mohawk Group
$36.19 /

+2.28 (+6.72%)

Hot Stocks
Children's Place reports Q4 comparable retail sales up 1%  07:02
03/09/21
03/09
07:02
03/09/21
07:02
PLCE

Children's Place

$79.99 /

+4.6 (+6.10%)

 
ShowHide Related Items >><<
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Monness Crespi
Monness Crespi downgrades Children's Place to Neutral, sees recovery priced in
02/16/21 Monness Crespi
Children's Place downgraded to Neutral from Buy at Monness Crespi
02/12/21 Citi
Children's Place downgraded to Sell from Neutral at Citi
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

Earnings
Children's Place reports Q4 adjusted EPS $1.01, consensus (23c) » 07:02
03/09/21
03/09
07:02
03/09/21
07:02
PLCE

Children's Place

$79.99 /

+4.6 (+6.10%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Monness Crespi
Monness Crespi downgrades Children's Place to Neutral, sees recovery priced in
02/16/21 Monness Crespi
Children's Place downgraded to Neutral from Buy at Monness Crespi
02/12/21 Citi
Children's Place downgraded to Sell from Neutral at Citi
PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

PLCE Children's Place
$79.99 /

+4.6 (+6.10%)

Earnings
Cantel Medical reports Q2 non-GAAP EPS 79c, consensus 50c » 07:01
03/09/21
03/09
07:01
03/09/21
07:01
CMD

Cantel Medical

$73.29 /

-1.9 (-2.53%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMD Cantel Medical
$73.29 /

-1.9 (-2.53%)

CMD Cantel Medical
$73.29 /

-1.9 (-2.53%)

01/13/21 Baird
Steris price target raised to $230 from $200 at BairdCantel Medical
01/13/21 Needham
Cantel Medical downgraded to Hold from Buy at Needham
01/13/21 Needham
Cantel Medical downgraded to Hold from Buy at Needham
01/12/21 Sidoti
Cantel Medical downgraded to Neutral from Buy at Sidoti
CMD Cantel Medical
$73.29 /

-1.9 (-2.53%)

CMD Cantel Medical
$73.29 /

-1.9 (-2.53%)

CMD Cantel Medical
$73.29 /

-1.9 (-2.53%)

Recommendations
Datto price target lowered to $27 from $38 at BMO Capital » 07:01
03/09/21
03/09
07:01
03/09/21
07:01
MSP

Datto

$24.27 /

+0.55 (+2.32%)

, MSFT

Microsoft

$227.42 /

-4.18 (-1.80%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$24.27 /

+0.55 (+2.32%)

MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

MSP Datto
$24.27 /

+0.55 (+2.32%)

03/08/21 RBC Capital
Datto price target lowered to $34 from $39 at RBC Capital
12/17/20 Barclays
Datto upgraded to Overweight with $35 target at Barclays
12/17/20 Barclays
Datto upgraded to Overweight from Equal Weight at Barclays
11/17/20 Citi
Datto initiated with a Neutral at Citi
MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

03/08/21 BofA
BofA says buy AMD and Nvidia as Steam data points to GPU upgrade tailwinds
03/08/21
Fly Intel: Top five analyst upgrades
03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
03/08/21 Goldman Sachs
Microsoft upgraded to Conviction Buy from Buy at Goldman Sachs
MSP Datto
$24.27 /

+0.55 (+2.32%)

MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

  • 21
    Oct
MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

MSP Datto
$24.27 /

+0.55 (+2.32%)

MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

MSP Datto
$24.27 /

+0.55 (+2.32%)

MSFT Microsoft
$227.42 /

-4.18 (-1.80%)

Recommendations
Liberty Latin America price target raised to $14 from $12 at Barclays » 07:00
03/09/21
03/09
07:00
03/09/21
07:00
LILA

Liberty Latin America

$13.33 /

+0.3301 (+2.54%)

Barclays analyst Mathieu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LILA Liberty Latin America
$13.33 /

+0.3301 (+2.54%)

LILA Liberty Latin America
$13.33 /

+0.3301 (+2.54%)

11/05/20 Scotiabank
Liberty Latin America downgraded to Underperform at Scotiabank
11/05/20 Scotiabank
Liberty Latin America downgraded to Underperform from Sector Perform at Scotiabank
10/09/20 Morgan Stanley
Liberty Latin America upgraded to Overweight at Morgan Stanley
03/12/20 HSBC
Liberty Latin America upgraded to Buy from Hold at HSBC
LILA Liberty Latin America
$13.33 /

+0.3301 (+2.54%)

LILA Liberty Latin America
$13.33 /

+0.3301 (+2.54%)

LILA Liberty Latin America
$13.33 /

+0.3301 (+2.54%)

Recommendations
McAfee price target raised to $28 from $26 at Mizuho » 06:59
03/09/21
03/09
06:59
03/09/21
06:59
MCFE

McAfee

$23.83 /

+2.58 (+12.14%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCFE McAfee
$23.83 /

+2.58 (+12.14%)

MCFE McAfee
$23.83 /

+2.58 (+12.14%)

06:40 Today RBC Capital
McAfee price target raised to $24 from $21 at RBC Capital
03/08/21 Mizuho
McAfee price target raised to $28 at Mizuho after enterprise security sale
02/24/21 Deutsche Bank
Deutsche upgrades McAfee on 'best-in-class' consumer security unit
02/24/21 Mizuho
McAfee price target raised to $26 from $25 at Mizuho
MCFE McAfee
$23.83 /

+2.58 (+12.14%)

  • 22
    Oct
MCFE McAfee
$23.83 /

+2.58 (+12.14%)

MCFE McAfee
$23.83 /

+2.58 (+12.14%)

Recommendations
MasterCard price target raised to $430 from $400 at Mizuho » 06:57
03/09/21
03/09
06:57
03/09/21
06:57
MA

MasterCard

$371.34 /

+10.55 (+2.92%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$371.34 /

+10.55 (+2.92%)

MA MasterCard
$371.34 /

+10.55 (+2.92%)

03/05/21 Truist
MasterCard price target raised to $450 from $415 at Truist
02/01/21 BofA
US 1 List changes at BofA
01/27/21 KeyBanc
MasterCard downgraded to Sector Weight at KeyBanc given reduced visibility
01/27/21 Bernstein
MasterCard reinitiated with an Outperform at Bernstein
MA MasterCard
$371.34 /

+10.55 (+2.92%)

MA MasterCard
$371.34 /

+10.55 (+2.92%)

MA MasterCard
$371.34 /

+10.55 (+2.92%)

MA MasterCard
$371.34 /

+10.55 (+2.92%)

Upgrade
Camtek upgraded to Buy amid market pullback at Stifel » 06:57
03/09/21
03/09
06:57
03/09/21
06:57
CAMT

Camtek

$25.45 /

-0.8 (-3.05%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAMT Camtek
$25.45 /

-0.8 (-3.05%)

CAMT Camtek
$25.45 /

-0.8 (-3.05%)

03/08/21 Stifel
Camtek upgraded to Buy from Hold at Stifel
02/10/21 B. Riley Securities
Camtek price target raised to $32 from $29 at B. Riley Securities
01/25/21 B. Riley Securities
Camtek price target raised to $29 from $24 at B. Riley Securities
11/24/20 Stifel
Camtek initiated with a Hold at Stifel
CAMT Camtek
$25.45 /

-0.8 (-3.05%)

  • 19
    Nov
Earnings
Titan Medical announces two future corporate milestones » 06:56
03/09/21
03/09
06:56
03/09/21
06:56
TMDI

Titan Medical

$1.77 /

+0.04 (+2.31%)

, MDT

Medtronic

$116.67 /

-1.5899 (-1.34%)

Titan Medical (TMDI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMDI Titan Medical
$1.77 /

+0.04 (+2.31%)

MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

TMDI Titan Medical
$1.77 /

+0.04 (+2.31%)

03/31/20 Piper Sandler
Titan Medical price target lowered to $1 from $1.50 at Piper Sandler
MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

  • 06
    Jan
MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

MDT Medtronic
$116.67 /

-1.5899 (-1.34%)

Hot Stocks
Eli Lilly chief ethics, compliance officer Melissa Barnes to retire » 06:56
03/09/21
03/09
06:56
03/09/21
06:56
LLY

Eli Lilly

$207.07 /

-0.005 (-0.00%)

Eli Lilly announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

03/02/21 JPMorgan
Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
02/18/21 Piper Sandler
Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
02/12/21 Cowen
Eli Lilly price target raised to $235 from $195 at Cowen
LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

LLY Eli Lilly
$207.07 /

-0.005 (-0.00%)

Recommendations
Cigna price target raised to $264 from $229 at Mizuho » 06:53
03/09/21
03/09
06:53
03/09/21
06:53
CI

Cigna

$234.86 /

+4.97 (+2.16%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CI Cigna
$234.86 /

+4.97 (+2.16%)

CI Cigna
$234.86 /

+4.97 (+2.16%)

03/03/21 Piper Sandler
Cigna acquisition 'incremental negative' for Hims & Hers, says Piper Sandler
02/05/21 Deutsche Bank
Cigna price target lowered to $270 from $280 at Deutsche Bank
02/05/21 Citi
Cigna undervalued after 'excessive' selloff, says Citi
02/01/21 BofA
US 1 List changes at BofA
CI Cigna
$234.86 /

+4.97 (+2.16%)

CI Cigna
$234.86 /

+4.97 (+2.16%)

CI Cigna
$234.86 /

+4.97 (+2.16%)

CI Cigna
$234.86 /

+4.97 (+2.16%)

Upgrade
Zynex upgraded to Outperform from Market Perform at Northland » 06:52
03/09/21
03/09
06:52
03/09/21
06:52
ZYXI

Zynex

/

+

Northland analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYXI Zynex
/

+

ZYXI Zynex
/

+

02/26/21 B. Riley Securities
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley Securities
Zynex downgraded to Neutral from Buy at B. Riley Securities
01/29/21 Piper Sandler
Zynex downgraded to Neutral from Overweight at Piper Sandler
01/28/21 Northland
Zynex downgraded to Market Perform from Outperform at Northland
ZYXI Zynex
/

+

  • 15
    Jul
ZYXI Zynex
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.